Icon
+91 94997 68112
Login Register

DORYX MPC - (60,120 mg; Tablet, Delayed Release)

DOXYCYCLINE HYCLATE Mayne Pharma
60,120 mg; Tablet, Delayed Release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
 None
Indicated for treatment of the following respiratory tract infections: Respiratory tract infections caused by Mycoplasma pneumoniae. susceptibility to the drug: Respiratory tract infections caused by Haemophilus influenzae.
Yes
***** ******** ***** ********* **** ** ************* ** ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) - ** ******* *** *** **** **** **-****** **** ******** ** *** ****. ***** ***** ** ** ***. ***** *** *** **** **** ** ** ***** *** ** ****** ******* *.*. ******* (*** **, ****) *** ******* (*** *, ****). '*** *** ********* *** ***** *** **** **** *** *** ******** ** ******. '*** **** ******* ** ********** ******* *** *** **** ********* ** ***. ***** ***** **** *** ** **** ** ****** *** ******* ****** ****** ** '*** ****** *.*. *** *, ****.
DORYX MPC Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
**** ******* ******* ******* ******* *******
***** ******* ******* ******* ******* *******
******** ****** ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** *** **, **** ******* ** ************ ****** **** ********
***** *** \ ** *** **, **** ******* ******** *** ****** *******
******** ****** ** \ ** **** **, **** ******* **** ****** **** ********
  1. *** *, **** : ***** ******** ***** ********* **** ** ************* ** ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) - ** *******
  2. *** **, **** : ***** **** ***** *** **** ** ** ** ********.
  3. *** **, **** : **** *** ********* ******** *** ******* ***** ***. ********* **** ** ******** *** *** **** ***********. *****://***.**********.***.***/**********_****/*********/****/******************.***
  4. *** **, **** : ***** ******* **** ****, ********* ** ********** **** *** ****** ******* ***** *** ** ***** **, **** ** **
  5. *** **, **** : ***** ******* **** *****, ***** *** ***** ** ********** *** *** *****.
  6. *** **, **** : ***** ***** * **** ******* ******** ** ******* ******* (*** **, ****), ******* (*** **, ****) *** ******* (*** **, ****)
  7. *** **, **** : ********** ********* **** ******** ******, ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.